Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 26

Results For "EDS"

1936 News Found

Asahi Kasei secures global rights to novel Alchemedicine preclinical compounds
News | February 26, 2026

Asahi Kasei secures global rights to novel Alchemedicine preclinical compounds

Asahi Kasei Pharma receives worldwide exclusive rights for the research, development, manufacturing, and marketing of the active ingredients


Caplin Steriles gets USFDA approval for Sodium Phosphate injection
Drug Approval | February 25, 2026

Caplin Steriles gets USFDA approval for Sodium Phosphate injection

Sodium Phosphates Injection is indicated as a source of phosphorus, for addition to large volume intravenous fluids, to prevent or correct hypophosphatemia in patients with restricted or no oral intake


Eris Lifesciences partnership with Natco Pharma for Semaglutide launch in India
News | February 24, 2026

Eris Lifesciences partnership with Natco Pharma for Semaglutide launch in India

The product will target Type 2 diabetes management aligning with unmet needs in India’s expanding metabolic care landscape


Colgate joins hands with Haryana to bring oral health education to 5.7 million school children
Healthcare | February 24, 2026

Colgate joins hands with Haryana to bring oral health education to 5.7 million school children

This partnership represents a systemic shift from awareness to large-scale action for 57 lakh children


Bayer introduces chemo-free treatment option for advanced prostate cancer in India
News | February 24, 2026

Bayer introduces chemo-free treatment option for advanced prostate cancer in India

Prostate cancer is one of the fastest-growing cancers in India, with approximately 37,948 new cases each year


FDA approves Lilly's Zepbound multi-dose KwikPen for obesity treatment
Drug Approval | February 24, 2026

FDA approves Lilly's Zepbound multi-dose KwikPen for obesity treatment

In 2025, over 1 million patients accessed Lilly treatments through LillyDirect


UK pours £20 million into cutting?edge tech to tackle drug & alcohol addiction
News | February 24, 2026

UK pours £20 million into cutting?edge tech to tackle drug & alcohol addiction

The funding comes under the AHG Catalysing Innovation Awards, part of the Addiction Healthcare Goals programme led by the Office for Life Sciences


Ultragenyx bags FDA priority review for groundbreaking GSDIa gene therapy
Drug Approval | February 24, 2026

Ultragenyx bags FDA priority review for groundbreaking GSDIa gene therapy

If approved, DTX401 would be the first treatment to address the disease at its root cause


Artemis Medicare to manage 650-bed VIMHANS Hospital in Rs. 520 South Delhi expansion
Hospitals | February 23, 2026

Artemis Medicare to manage 650-bed VIMHANS Hospital in Rs. 520 South Delhi expansion

The project entails a total planned capital expenditure of approximately Rs. 500 - 520 crore